Award type :
Product Development Award
Product Development Award
Product type :
Vaccines
Vaccines
Award year :
2021
2021
Project start date :
07 / 07 / 2021
07 / 07 / 2021
Project end date :
12 / 30 / 2022
12 / 30 / 2022
Project duration (months) :
11
11
Development stage :
Preclinical
Preclinical
Target disease :
Polio
Polio
Region served :
World
World
Recipient organization / Country of funding recipient organization :
Yonsei University / Republic of Korea
Yonsei University / Republic of Korea
Collaborator(s) / Country :
LG Chem / Republic of Korea
LG Chem / Republic of Korea
Funding amount(KRW) :
500,000,000
500,000,000
Yonsei University is collaborating with LG Chem for the validation of a low-cost, virus-free vaccine platform with the development of a cell-culture-independent, genome-free polio vaccine produced in a bacterial host utilizing RNA as chaperone. The development of an injectable polio vaccine prepared without recourse to growing wild polio virus is not only safer but can also be easily manufactured in response to an urgent need for vaccines in the context of possible post-eradication outbreaks. The virus-free platform using bacterial host production may also be applied to other diseases.